Biological applications of chitin, chitosan, oligosaccharides, and their derivatives

Chitin and Chitosan Derivatives: Advances in Drug Discovery and Developments

Volumn , Issue , 2013, Pages 223-242

  Manivasagan, Panchanathan ^a   Senthilkumar, Kalimuthu ^a   Venkatesan, Jayachandran ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013924914     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15636     Document Type: Chapter

References (145)

1. Agnihotri, SA, NN Mallikarjuna, and TM Aminabhavi. 2004. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. Journal of Controlled Release 100(1):5-28.
2. Aiedeh, K and MO Taha. 2001. Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads. European Journal of Pharmaceutical Sciences 13(2):159-168.
3. Akiyama, K, K Kawazu, and A Kobayashi. 1995. A novel method for chemo-enzymatic synthesis of elicitor-active chitosan oligomers and partially N-deacetylated chitin oligomers using N-acylated chitotrioses as substrates in a lysozyme-catalyzed transglycosylation reaction system. Carbohydrate Research 279:151-160.
4. Amidi, M, SG Romeijn, G Borchard, HE Junginger, WE Hennink, and W Jiskoot. 2006. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. Journal of Controlled Release 111(1):107-116.
5. Arnaud, TM, B de Barros Neto, and FB Diniz. 2010. Chitosan effect on dental enamel de-remineralization: An in vitro evaluation. Journal of Dentistry 38(11):848-852.
6. Baba, Y, H Noma, R Nakayama, and Y Matsushita. 2002. Preparation of chitosan derivatives containing methylthiocarbamoyl and phenylthiocarbamoyl groups and their selective adsorption of copper (II) over iron (III). Analytical Sciences 18(3):359-361.
7. Bacon, A, J Makin, PJ Sizer et al. 2000. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infection and Immunity 68(10):5764-5770.
8. Baldwin Jr, AS. 2001. Perspective series-NF-kB in defense and disease.The transcription factor NF-kB and human disease. Journal of Clinical Investigation 107(1):3-6.
9. Benhamou, N, PJ Lafontaine, and M Nicole. 1994. Induction of systemic resistance to Fusarium crown and root rot in tomato plants by seed treatment with chitosan. Phytopathology 84(12):1432-1444.
10. Bernkop-Schnürch, A and S Dünnhaupt. 2012. Chitosan based drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics 81(3):463-469.
11. Bernkop-Schnürch, A, D Guggi, and Y Pinter. 2004. Thiolated chitosans: Development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. Journal of Controlled Release 94(1):177-186.
12. Bhaskara Reddy, MV, J Arul, P Angers, and L Couture. 1999. Chitosan treatment of wheat seeds induces resistance to Fusarium graminearum and improves seed quality. Journal of Agricultural and Food Chemistry 47(3):1208-1216.
13. Bodnar, M, JF Hartmann, and J Borbely. 2005. Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 6(5):2521-2527.
14. Bodnar, M, JF Hartmann, and J Borbely. 2006. Synthesis and study of cross-linked chitosan-N-poly (ethylene glycol) nanoparticles. Biomacromolecules 7(11):3030-3036.
15. Chang, DS, HR Cho, HY Goo, and WK Choe. 1989. A development of food preservative with the waste of crab processing. Bulletin of the Korean Fisheries Society 22(2):70-78.
16. Chang, HY, JJ Chen, F Fang, and Z Chen. 2004. Enhancement of antibody response by chitosan, a novel adjuvant of inactivated influenza vaccine. Chinese Journal of Biologicals 17(6):21-24.
17. Chang, Y-C, D-B Shieh, C-H Chang, and D-H Chen. 2005. Conjugation of monodisperse chitosan-bound magnetic nanocarrier with epirubicin for targeted cancer therapy. Journal of Biomedical Nanotechnology 1(2):196-201.
18. Chatelet, C, O Damour, and A Domard. 2001. Influence of the degree of acetylation on some biological properties of chitosan films. Biomaterials 22(3):261-268.
19. Chen, RH and JS Chen. 2000. Changes of polydispersity and limiting molecular weight of ultrasound-treated chitosan. Advances in Chitin Science 4:361-366.
20. +/complex. Carbohydrate Polymers 60(1):33-38.
21. Chen, X-G, Z Wang, W-S Liu, and H-J Park. 2002. The effect of carboxymethyl-chitosan on proliferation and collagen secretion of normal and keloid skin fibroblasts. Biomaterials 23(23):4609-4614.
22. Chourasia, MK and SK Jain. 2004. Polysaccharides for colon targeted drug delivery. Drug Delivery 11(2):129-148.
23. Cuero, RG, G Osuji, and A Washington. 1991. N-carboxymethylchitosan inhibition of aflatoxin production: role of zinc. Biotechnology Letters 13(6):441-444.
24. Da Silva, CA, C Chalouni, A Williams, D Hartl, CG Lee, and JA Elias. 2009. Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. The Journal of Immunology 182(6):3573-3582.
25. Darmadji, P and M Izumimoto. 1994. Effect of chitosan in meat preservation. Meat Science 38(2):243-254.
26. DiMasi, JA, RW Hansen, and HG Grabowski. 2003. The price of innovation: New estimates of drug development costs. Journal of Health Economics 22(2):151-186.
27. Domard, A and M Domard. 2002. Chitosan: Structure-properties relationship and biomedical applications. Polymeric Biomaterials 9:187-212.
28. Drayton, DL, S Liao, RH Mounzer, and NH Ruddle. 2006. Lymphoid organ development: From ontogeny to neogenesis. Nature Immunology 7(4):344-353.
29. Dufes, C, J-M Muller, W Couet, J-C Olivier, IF Uchegbu, and AG Schätzlein. 2004. Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharmaceutical Research 21(1):101-107.
30. Duncan, R. 2003. The dawning era of polymer therapeutics. Nature Reviews Drug Discovery 2(5):347-360.
31. Duncan, R. 2006. Polymer conjugates for drug targeting. From inspired to inspiration! Preface. Journal of Drug Targeting 14(6):333-335.
32. El Ghaouth, A, J Arul, A Asselin, and N Benhamou. 1992. Antifungal activity of chitosan on post-harvest pathogens: Induction of morphological and cytological alterations in Rhizopus stolonifer. Mycological Research 96(9):769-779.
33. Epstein, FH, PJ Barnes, and M Karin. 1997. Nuclear factor-κB-A pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 336(15):1066-1071.
34. Felt, O, P Buri, and R Gurny. 1998. Chitosan: A unique polysaccharide for drug delivery. Drug Development and Industrial Pharmacy 24(11):979-993.
35. Field, CE, LF Pivarnik, SM Barnett, and AG Rand. 1986. Utilization of glucose oxidase for extending the shelf-life of fish. Journal of Food Science 51(1):66-70.
36. Franco, TT and MG Peter. 2011. Advances in chitin and chitosan research. Polymer International 60(6):873-874.
37. Franklin, TJ and GA Snow. 1981. Biochemistry of Antimicrobial Action. Chapman & Hall. London.
38. Goldberg, M, R Langer, and X Jia. 2007. Nanostructured materials for applications in drug delivery and tissue engineering. Journal of Biomaterials Science, Polymer Edition 18(3):241-268.
39. Gorzelanny, C, B Pöppelmann, E Strozyk, BM Moerschbacher, and SW Schneider. 2007. Specific interaction between chitosan and matrix metalloprotease 2 decreases the invasive activity of human melanoma cells. Biomacromolecules 8(10):3035-3040.
40. Hai, L, TB Diep, N Nagasawa, F Yoshii, and T Kume. 2003. Radiation depolymerization of chitosan to prepare oligomers. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms 208:466-470.
41. Hassan, EE and JM Gallo. 1993. Targeting anticancer drugs to the brain. I: Enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. Journal of Drug Targeting 1(1):7-14.
42. Hejazi, R and M Amiji. 2003. Chitosan-based gastrointestinal delivery systems. Journal of Controlled Release 89(2):151-165.
43. Hirano, S. 1996. Chitin biotechnology applications. Biotechnology Annual Review 2:237-258.
44. Hu, J, PE Van den Steen, Q-XA Sang, and G Opdenakker. 2007. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nature Reviews Drug Discovery 6(6):480-498.
45. Huang, R, E Mendis, N Rajapakse, and S-K Kim. 2006. Strong electronic charge as an important factor for anticancer activity of chitooligosaccharides (COS). Life Sciences 78(20):2399-2408.
46. Il’ina, AV and VP Varlamov. 2004. Hydrolysis of chitosan in lactic acid. Applied Biochemistry and Microbiology 40(3):300-303.
47. Ishii, T, Y Okahata, and T Sato. 2001. Mechanism of cell transfection with plasmid/chitosan complexes. Biochimica et Biophysica Acta (BBA)-Biomembranes 1514(1):51-64.
48. Jain, SK and A Jain. 2008. Target-specific drug release to the colon. Expert Opinion on Drug Delivery 5(5):483-498.
49. Jam, SK, A Jain, Y Gupta, P Khare, and M Kannandasan. 2008. Targeted delivery of 5-ASA to colon using chitosan hydrogel microspheres. Journal of Drug Delivery Science and Technology 18(5):315-321.
50. Jemal, A, RSiegel, E Ward, Y Hao, J Xu, and MJ Thun. 2009. Cancer statistics, 2009. CA: A Cancer Journal for Clinicians 59(4):225-249.
51. Jeon, Y-J, F Shahidi, and S-K Kim. 2000. Preparation of chitin and chitosan oligomers and their applications in physiological functional foods. Food Reviews International 16(2):159-176.
52. Jia, Z and W Xu. 2001. Synthesis and antibacterial activities of quaternary ammonium salt of chitosan. Carbohydrate Research 333(1):1-6.
53. Kato, Y, H Onishi, and Y Machida. 2004. N-succinyl-chitosan as a drug carrier: Water-insoluble and watersoluble conjugates. Biomaterials 25(5):907-915.
54. Kato, Y, H Onishi, and Y Machida. 2005. Contribution of chitosan and its derivatives to cancer chemotherapy. In Vivo 19(1):301-310.
55. Kendra, DF and LA Hadwiger. 1984. Characterization of the smallest chitosan oligomer that is maximally antifungal to Fusarium solani and elicits pisatin formation in Pisum sativum. Experimental Mycology 8(3):276-281.
56. Kim, C-H, S-Y Kim, and K-S Choi. 1997. Synthesis and antibacterial activity of water-soluble chitin derivatives. Polymers for Advanced Technologies 8(5):319-325.
57. Kim, J-H, Y-S Kim, K Park et al. 2008. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. Journal of Controlled Release 127(1):41-49.
58. Kim, K, S Kwon, JH Park et al. 2005. Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. Biomacromolecules 6(2):1154.
59. Kim, M-S, HJ You, MK You, N-S Kim, BS Shim, and H-M Kim. 2004. Inhibitory effect of water-soluble chitosan on TNF-α and IL-8 secretion from HMC-1 cells. Immunopharmacology and Immunotoxicology 26(3):401-409.
60. Kim, M-M and S-K Kim. 2006. Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts. FEBS Letters 580(11):2661-2666.
61. Kim, S-K and N Rajapakse. 2005. Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohydrate Polymers 62(4):357-368.
62. Knorr, D. 1984. Use of chitinous polymers in food: A challenge for food research and development. Food Technology 38:85-87.
63. Kochkina, ZM and SN Chirkov. 2000. Effect of chitosan derivatives on the development of phage infection in cultured Bacillus thuringiensis. Mikrobiologiia 69(2):266-269.
64. Kulikov, SN, SN Chirkov, AV Il’ina, SA Lopatin, and VP Varlamov. 2006. Effect of the molecular weight of chitosan on its antiviral activity in plants. Applied Biochemistry and Microbiology 42(2):200-203.
65. Kumar, MNVR, Raa Muzzarelli, C Muzzarelli, H Sashiwa, and AJ Domb. 2004. Chitosan chemistry and pharmaceutical perspectives. Chemical Reviews-Columbus 104(12):6017-6084.
66. Kurita, K. 1998. Chemistry and application of chitin and chitosan. Polymer Degradation and Stability 59(1):117-120.
67. Kuroiwa, T, S Ichikawa, O Hiruta, S Sato, and S Mukataka. 2002. Factors affecting the composition of oligosaccharides produced in chitosan hydrolysis using immobilized chitosanases. Biotechnology Progress 18(5):969-974.
68. Kwon, S, JH Park, H Chung, IC Kwon, SY Jeong, and I-S Kim. 2003. Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid. Langmuir 19(24):10188-10193.
69. Laflamme, P, N Benhamou, G Bussières, and M Dessureault. 2000. Differential effect of chitosan on root rot fungal pathogens in forest nurseries. Canadian Journal of Botany 77(10):1460-1468.
70. Langer, R. 1998. Drug delivery and targeting. Nature 392(6679):5-9.
71. Lavall, RL, OBG Assis, and SP Campana-Filho. 2007. β-Chitin from the pens of Loligo sp.: Extraction and characterization. Bioresource Technology 98(13):2465-2472.
72. Lee, W-L, H-T Chao, M-H Cheng, and P-H Wang. 2008a. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. Maturitas 60(2):92-107.
73. Lee, D-X, W-S Xia, and J-L Zhang. 2008b. Enzymatic preparation of chitooligosaccharides by commercial lipase. Food Chemistry 111(2):291-295.
74. Li, Z, XP Zhuang, XF Liu, YL Guan, and K De Yao. 2002. Study on antibacterial O-carboxymethylated chitosan/cellulose blend film from LiCl/N, N-dimethylacetamide solution. Polymer 43(4):1541-1547.
75. Lin, A, Y Liu, Y Huang et al. 2008. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. International Journal of Pharmaceutics 359(1):247-253.
76. Lin, S-B, Y-C Lin, and H-H Chen. 2009. Low molecular weight chitosan prepared with the aid of cellulase, lysozyme and chitinase: Characterisation and antibacterial activity. Food Chemistry 116(1):47-53.
77. Liu, J-n, W-s Xia, and J-l Zhang. 2008. Effects of chitosans physico-chemical properties on binding capacities of lipid and bile salts in vitro. Food Science 1:45-49.
78. Macarthur, M, GL Hold, and EM El-Omar. 2004. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. American Journal of Physiology-Gastrointestinal and Liver Physiology 286(4):G515-G520.
79. Mao, S, X Shuai, F Unger, M Simon, D Bi, and T Kissel. 2004. The depolymerization of chitosan: Effects on physicochemical and biological properties. International Journal of Pharmaceutics 281(1):45-54.
80. Mellman, I, G Coukos, and G Dranoff. 2011. Cancer immunotherapy comes of age. Nature 480(7378):480-489.
81. Moon, J-S, H-K Kim, HC Koo et al. 2007. The antibacterial and immunostimulative effect of chitosan-oligosaccharides against infection by Staphylococcus aureus isolated from bovine mastitis. Applied Microbiology and Biotechnology 75(5):989-998.
82. Morganti, P and G Morganti. 2008. Chitin nanofibrils for advanced cosmeceuticals. Clinics in Dermatology 26(4):334-340.
83. Muzzarelli, R, R Tarsi, O Filippini, E Giovanetti, G Biagini, and PE Varaldo. 1990. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrobial Agents and Chemotherapy 34(10):2019-2023.
84. Muzzarelli, RAA, P Ilari, R Tarsi, B Dubini, and W Xia. 1994. Chitosan from Absidia coerulea. Carbohydrate Polymers 25(1):45-50.
85. Muzzarelli, RAA, C Muzzarelli, R Tarsi, M Miliani, F Gabbanelli, and M Cartolari. 2001. Fungistatic activity of modified chitosans against Saprolegnia parasitica. Biomacromolecules 2(1):165-169.
86. Nam, K-S, Y-R C and Y-H Shon. 2001. Evaluation of the antimutagenic potential of chitosan oligosaccharide: Rec, Ames and Umu tests. Biotechnology Letters 23(12):971-975.
87. Ngo, Dai-Nghiep, Moon-Moo Kim, and Se-Kwon Kim. 2008a. Chitin oligosaccharides inhibit oxidative stress in live cells. Carbohydrate Polymers 74(2):228-234.
88. Ngo, D-N, S-H Lee, M-M Kim, and S-K Kim. 2009. Production of chitin oligosaccharides with different molecular weights and their antioxidant effect in RAW 264.7 cells. Journal of Functional Foods 1(2):188-198.
89. Ngo, D-N, Z-J Qian, J-Y Je, M-M Kim, and S-K Kim. 2008b. Aminoethyl chitooligosaccharides inhibit the activity of angiotensin converting enzyme. Process Biochemistry 43(1):119-123.
90. Nishimura, K, S Nishimura, N Nishi, I Saiki, S Tokura, and I Azuma. 1984. Immunological activity of chitin and its derivatives. Vaccine 2(1):93-99.
91. Ogawara, K-i, M Yoshida, K Higaki et al. 1999. Hepatic uptake of polystyrene microspheres in rats: Effect of particle size on intrahepatic distribution. Journal of Controlled Release 59(1):15-22.
92. Ohya, Y, M Shiratani, H Kobayashi, and T Ouchi. 1994. Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. Journal of Macromolecular Science-Pure and Applied Chemistry 31(5):629-642.
93. Opanasopit, P, T Ngawhirunpat, T Rojanarata, C Choochottiros, and S Chirachanchai. 2007. N-Phthaloylchitosang-mPEG design for all-trans retinoic acid-loaded polymeric micelles. European Journal of Pharmaceutical Sciences 30(5):424-431.
94. Pankhurst, QA, J Connolly, SK Jones, and J Dobson. 2003. Applications of magnetic nanoparticles in biomedicine. Journal of Physics D: Applied Physics 36(13):R167.
95. Papineau, AM, DG Hoover, D Knorr, and DF Farkas. 1991. Antimicrobial effect of water-soluble chitosans with high hydrostatic pressure. Food Biotechnology 5(1):45-57.
96. Park, JS, TH Han, K Yong Lee et al. 2006. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: Endocytosis, exocytosis and drug release. Journal of Controlled Release 115(1):37-45.
97. Park, P-J, J-Y Je, and S-K Kim. 2003. Angiotensin I converting enzyme (ACE) inhibitory activity of heterochitooligosaccharides prepared from partially different deacetylated chitosans. Journal of Agricultural and Food Chemistry 51(17):4930-4934.
98. Park, P-J, J-Y Je, and S-K Kim. 2004. Free radical scavenging activities of differently deacetylated chitosans using an ESR spectrometer. Carbohydrate Polymers 55(1):17-22.
99. Patel, MP, RR Patel, and JK Patel. 2010. Chitosan mediated targeted drug delivery system: A review. Journal of Pharmacy & Pharmaceutical Sciences 13(4):536-557.
100. Peniche-Covas, C, LW Alvarez, and W Argüelles-Monal. 1992. The adsorption of mercuric ions by chitosan. Journal of Applied Polymer Science 46(7):1147-1150.
101. Peniston, QP and EL Johnson. 1980. Process for the manufacture of chitosan. US Patent No. 4,195,175 pp. 5-15.
102. Pospieszny, H and JG Atabekov. 1989. Effect of chitosan on the hypersensitive reaction of bean to alfalfa mosaic virus. Plant Science 62(1):29-31.
103. Pospieszny, H, S Chirkov, and J Atabekov. 1991. Induction of antiviral resistance in plants by chitosan. Plant Science 79(1):63-68.
104. Prabaharan, M and JF Mano. 2004. Chitosan-based particles as controlled drug delivery systems. Drug Delivery 12(1):41-57.
105. Qu, G, Z Yao, C Zhang, X Wu, and Q Ping. 2009. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation. European Journal of Pharmaceutical Sciences 37(2):98-105.
106. Rabea, EI, ME-T Badawy, CV Stevens, G Smagghe, and W Steurbaut. 2003. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 4(6):1457-1465.
107. Razdan, A and D Pettersson. 1994. Effect of chitin and chitosan on nutrient digestibility and plasma lipid concentrations in broiler chickens. British Journal of Nutrition 72(2):277-288.
108. Ribeiro, MP, A Espiga, D Silva et al. 2009. Development of a new chitosan hydrogel for wound dressing. Wound Repair and Regeneration 17(6):817-824.
109. Rotin, D, D Steele-Norwood, S Grinstein, and I Tannock. 1989. Requirement of the Na + /H+ exchanger for tumor growth. Cancer Research 49(1):205-211.
110. Sang Y, Hyuk, JE Lee, H Chung, IC Kwon, and SY Jeong. 2005. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. Journal of Controlled Release 103(1):235-243.
111. Savard, T, C Beaulieu, I Boucher, and CP Champagne. 2002. Antimicrobial action of hydrolyzed chitosan against spoilage yeasts and lactic acid bacteria of fermented vegetables. Journal of Food Protection 65(5):828-833.
112. Seymour, LW, K Ulbrich, SR Wedge, IC Hume, J Strohalm, and R Duncan. 1991. N-(2-hydroxypropyl) methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice. British Journal of Cancer 63(6):859.
113. Sharon, N and H Lis. 1993. Carbohydrates in cell recognition. Scientific American 268(1):82-89.
114. Simpson, BK, N Gagne, INA Ashie, and E Noroozi. 1997. Utilization of chitosan for preservation of raw shrimp (Pandalus borealis). Food Biotechnology 11(1):25-44.
115. Son, YJ, J-S Jang, Y Woo Cho et al. 2003. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycolchitosan nanoaggregates by EPR effect. Journal of Controlled Release 91(1):135-145.
116. Sosa, MAG, F Fazely, JA Koch, SV Vercellotti, and RM Ruprecht. 1991. N-Carboxymethylchitosan-N, O-sulfate as an anti-HIV-1 agent. Biochemical and Biophysical Research Communications 174(2):489-496.
117. Stössel, P and JL Leuba. 1984. Effect of chitosan, chitin and some aminosugars on growth of various soilborne phytopathogenic fungi. Journal of Phytopathology 111(1):82-90.
118. Strand, SP, KM Vårum, and K Østgaard. 2003. Interactions between chitosans and bacterial suspensions: Adsorption and flocculation. Colloids and Surfaces B: Biointerfaces 27(1):71-81.
119. Sudarshan, NR, DG Hoover, and D Knorr. 1992. Antibacterial action of chitosan. Food Biotechnology 6(3):257-272.
120. Sun, W, S Mao, D Mei, and T Kissel. 2008. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin. European Journal of Pharmaceutics and Biopharmaceutics 69(2):417-425.
121. Suzuki, K, T Mikami, Y Okawa, A Tokoro, S Suzuki, and M Suzuki. 1986. Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose. Carbohydrate Research 151:403.
122. Synowiecki, J and NA Al-Khateeb. 2003. Production, properties, and some new applications of chitin and its derivatives. Critical Reviews in Food Science and Nutrition 43(2):145-171.
123. Tokoro, A., Tatewaki, N., Suzuki, K., Mikami, T., Suzuki, S., Suzuki, M. 1988. Growth-inhibitory effect of hexa-N-acetylchitohexanse and chitohexaose against Meth-A solid tumor. Chemical & Pharmaceutical Bulletin 36(2):784-790.
124. Torchilin, V. 2008. Antibody-modified liposomes for cancer chemotherapy 5(9):1003-1025.
125. Torres, J, M Motoki, and M Karel. 1985. Microbial stabilization of intermediate moisture food surfaces I. Control of surface preservative concentration. Journal of Food Processing and Preservation 9(2): 75-92.
126. Tozaki, H, T Odoriba, N Okada et al. 2002. Chitosan capsules for colon-specific drug delivery: Enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. Journal of Controlled Release 82(1):51-61.
127. Tsai, G-J, Z-Y Wu, and W-H Su. 2000. Antibacterial activity of a chitooligosaccharide mixture prepared by cellulase digestion of shrimp chitosan and its application to milk preservation. Journal of Food Protection 63(6):747-752.
128. Ueno, H, T Mori, and T Fujinaga. 2001. Topical formulations and wound healing applications of chitosan. Advanced Drug Delivery Reviews 52(2):105-115.
129. Vanneman, M and G Dranoff. 2012. Combining immunotherapy and targeted therapies in cancer treatment. Nature Reviews Cancer 12(4):237-251.
130. Vriesendorp, R, AJM Donker, D de Zeeuw, PE de Jong, GK van der Hem, and JRH Brentjens. 1986. Effects of nonsteroidal anti inflammatory drugs on proteinuria. The American Journal of Medicine 81(2):84-94.
131. Wang, G-H. 1992. Inhibition and inactivation of five species of foodborne pathogens by chitosan. Journal of Food Protection 55:916.
132. Wang, S-H and J-C Chen. 2005. The protective effect of chitin and chitosan against Vibrio alginolyticus in white shrimp Litopenaeus vannamei. Fish & Shellfish Immunology 19(3):191-204.
133. Wang, Y-S, Q Jiang, R-S Li et al. 2008. Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel. Nanotechnology 19(14):145101.
134. Wu, S, X Liu, A Yeung et al. 2011. Plasma-modified biomaterials for self-antimicrobial applications. ACS Applied Materials & Interfaces 3(8): 2851-2860.
135. Xia, W, P Liu, J Zhang, and J Chen. 2011. Biological activities of chitosan and chitooligosaccharides. Food Hydrocolloids 25(2):170-179.
136. Yahara, T, T Koga, S Yoshida, S Nakagawa, H Deguchi, and K Shirouzu. 2003. Relationship between microvessel density and thermographic hot areas in breast cancer. Surgery Today 33(4):243-248.
137. Yang, KW, XR Li, ZL Yang, PZ Li, F Wang, and Y Liu. 2009a. Novel polyion complex micelles for liver targeted delivery of diammonium glycyrrhizinate: In vitro and in vivo characterization. Journal of Biomedical Materials Research Part A 88(1):140-148.
138. Yang, R, S-G Yang, W-S Shim et al. 2009b. Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates. Journal of Pharmaceutical Sciences 98(3):970-984.
139. Yang, X, Q Zhang, Y Wang et al. 2008. Self-aggregated nanoparticles from methoxy poly (ethylene glycol)-modified chitosan: Synthesis; characterization; aggregation and methotrexate release in vitro. Colloids and Surfaces B: Biointerfaces 61(2):125-131.
140. Yoon, HJ, ME Moon, HS Park, SY Im, and YH Kim. 2007. Chitosan oligosaccharide (COS) inhibits LPSinduced inflammatory effects in RAW 264.7 macrophage cells. Biochemical and Biophysical Research Communications 358(3):954-959.
141. You, J, X Li, F de Cui, Y-Z Du, H Yuan, and Fqiang Hu. 2008. Folate-conjugated polymer micelles for active targeting to cancer cells: Preparation, in vitro evaluation of targeting ability and cytotoxicity. Nanotechnology 19(4):045102.
142. Yuan, Z-X, X Sun, T Gong, H Ding, Y Fu, and Z-R Zhang. 2007. Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier. Journal of Drug Targeting 15(4):269-278.
143. Zhang, C, Yao C, G Qu et al. 2008. Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5-fluorouracil. Carbohydrate Polymers 72(3):390-397.
144. Zhang, U, Y Du, X Yu, M Mitsutomi, and S-i Aiba. 1999. Preparation of chitooligosaccharides from chitosan by a complex enzyme. Carbohydrate Research 320(3):257-260.
145. Zhong, H, MJ May, E Jimi, and S Ghosh. 2002. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Molecular Cell 9(3):625-636.